The Interference of Gamma Rays With Bone Mineral Density Measurements in Lu-177-PSMA and DOTATATE Therapy


Isikci N. I., Abuqbeitah M., DEMİR M.

JOURNAL OF CLINICAL DENSITOMETRY, vol.25, no.2, pp.237-243, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 2
  • Publication Date: 2022
  • Doi Number: 10.1016/j.jocd.2021.08.003
  • Journal Name: JOURNAL OF CLINICAL DENSITOMETRY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Page Numbers: pp.237-243
  • Keywords: BMD, DEXA, T-score, Lu-177-PSMA, Lu-177 DOTATATE, PROSTATE-CANCER, ABSORPTIOMETRY, MEN
  • Istanbul University Affiliated: No

Abstract

The main purpose was to describe the interference of gamma radiation emitted by Lu-177 with simultaneous bone mineral density BMD measures for patients undergoing Lu-177-PSMA and Lu-177 DOTATATE therapy. A cohort of 9 patients underwent Lu-177-PSMA therapy were randomly selected to speculate the activity in the abdominopelvic region. So that, SPECT/CT scan at 24 h was used with attenuation and scatter correction. The activities were derived from the delineated ROIs over the abdominopelvic zone showing a range of 34-274 MBq. Next, a water path was placed under spine phantom mimicking L1-L4 vertebrae and followed by consecutive DEXA scans made by Hologic 4500 W and GE-Lunar DPX-NT systems. Five scans were performed without/and with different Lu-177 activities 37, 185, 370 and 555 MBq under the same geometric conditions. The obtained BMD readings of L1-L4 by the Hologic device were 1.027, 1.024, 1.021, 1.013, and 1.006 g/cm(2) with presence of 0, 37, 185, 370, and 555 MBq Lu-177 activity, respectively. Whereas, in Lunar device, it was found as higher as 1.163, 1.121, 1.09, 1.072, and 1.043, respectively. There was no statistically significant difference between both devices (p(value) >= 0.05). The fluctuation ranges in the L1-L4 BMD readings at the presence of 37-555 MBq were 0.3%-2%, and 3.6%-10.3% for Hologic and Lunar systems, respectively. It was emphasized that gamma radiation emitted by Lu-177 relatively influence DEXA scans and the yielded BMD measures. Postponing DEXA scans as early as 8 d after Lu-177-PMSA and 11 d after Lu-177-DOTATATE therapies is recommended to avoid the erroneous contribution of gamma radiation and provide precise bone assessment.